SequelSEC

QUEST DIAGNOSTICS INC DGX

Services-Medical Laboratories · CIK 0001022079 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$11.56B
Fiscal year ended 2026-06-30
Operating income
$1.63B
Fiscal year ended 2026-06-30
Free cash flow
$1.35B
Fiscal year ended 2026-06-30

QUEST DIAGNOSTICS INC (DGX) reported revenue of $11.56B and net income of $1.06B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from QUEST DIAGNOSTICS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

QUEST DIAGNOSTICS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$11.56B
Cost of revenue$7.73B
Gross profit$3.83B
Operating income$1.63B
Net income$1.06B
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$1.40B
Income tax expense$320.00M
Diluted EPSUnavailable
Selling, general & administrative$2.04B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

QUEST DIAGNOSTICS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$626.00M
Total assets$16.94B
Current assets$2.84B
Total liabilitiesUnavailable
Current liabilities$1.79B
Total equity incl. NCI$7.82B
Temporary (mezzanine) equity$80.00M
Inventory$233.00M
Accounts receivable$1.67B
Goodwill$9.11B
Long-term debt$5.63B
Accounts payableUnavailable

Cash flow

QUEST DIAGNOSTICS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$1.90B
Capital expenditures$554.00M
Investing cash flow-$678.00M
Financing cash flow-$915.00M
Net change in cash$307.00M
Stock-based compensation$88.00M
Common dividends paid$363.00M
Common share repurchasesUnavailable
Depreciation & amortization$580.00M

Derived

QUEST DIAGNOSTICS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$1.35B
Gross margin33.1%
Operating margin14.1%
FCF margin11.7%
SBC / revenue0.8%
Current ratio1.59x
Revenue YoY growth9.9%
Net margin9.2%
R&D / revenueUnavailable
CapEx / revenue4.8%
Long-term debt / equity0.72x
Effective tax rate22.8%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open DGX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-23View SEC filing
10-Q · Filed 2026-04-22View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-10-21View SEC filing
10-Q · Filed 2025-07-23View SEC filing
10-Q · Filed 2025-04-23View SEC filing

Companies in the same industry

ACON ADVB AMS BDSX BGLC BLLN CAI CDNA CELC CFOR CSTL FCHS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.